(BALL) Ball - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0584981064
Stock: Aluminum Cans, Aerosol Containers, Bottles, Cups, Slugs
Total Rating 64
Risk 83
Buy Signal 0.30
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.56% |
| Yield on Cost 5y | 0.95% |
| Yield CAGR 5y | 3.39% |
| Payout Consistency | 95.7% |
| Payout Ratio | 23.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.1% |
| Relative Tail Risk | -8.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.01 |
| Alpha | 22.83 |
| Character TTM | |
|---|---|
| Beta | 0.429 |
| Beta Downside | 0.454 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.62% |
| CAGR/Max DD | 0.24 |
Description: BALL Ball January 02, 2026
Ball Corporation (NYSE: BALL) is a global supplier of aluminum packaging, serving beverage, personal-care, and household-product manufacturers across the United States, Brazil, and other markets. Its product line includes carbonated-drink cans, beer cans, energy-drink cans, extruded aerosol containers, resealable bottles, cups, and aluminum slugs. Founded in 1880, the company is headquartered in Westminster, Colorado, and operates within the GICS sub-industry “Metal, Glass & Plastic Containers.”
Key metrics (FY 2024): revenue ≈ $15.8 bn, adjusted EBITDA margin ≈ 14%, and free cash flow conversion ≈ 75%. The business is highly sensitive to aluminum commodity prices and benefits from the “circular economy” trend-U.S. recycling rates for aluminum cans have risen to ~53%, supporting cost-efficiency and ESG positioning. Demand drivers include steady growth in carbonated-soft-drink volumes (+2% YoY) and a robust rebound in beer consumption in Brazil (+5% YoY), both of which boost container sales.
For a deeper quantitative view, you might explore ValueRay’s analyst dashboard to assess BALL’s valuation and risk profile.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 911.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 6.13 > 1.0 |
| NWC/Revenue: 4.76% < 20% (prev -0.05%; Δ 4.81% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.26b > Net Income 911.0m |
| Net Debt (5.80b) to EBITDA (2.08b): 2.80 < 3 |
| Current Ratio: 1.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (268.3m) vs 12m ago -9.16% < -2% |
| Gross Margin: 14.84% > 18% (prev 0.16%; Δ 1469 % > 0.5%) |
| Asset Turnover: 70.75% > 50% (prev 66.93%; Δ 3.82% > 0%) |
| Interest Coverage Ratio: 4.63 > 6 (EBITDA TTM 2.08b / Interest Expense TTM 314.0m) |
Altman Z'' 3.16
| A: 0.03 (Total Current Assets 6.11b - Total Current Liabilities 5.49b) / Total Assets 19.52b |
| B: 0.62 (Retained Earnings 12.07b / Total Assets 19.52b) |
| C: 0.08 (EBIT TTM 1.45b / Avg Total Assets 18.58b) |
| D: 0.38 (Book Value of Equity 5.42b / Total Liabilities 14.10b) |
| Altman-Z'' Score: 3.16 = A |
Beneish M -2.87
| DSRI: 1.08 (Receivables 2.61b/2.17b, Revenue 13.14b/11.80b) |
| GMI: 1.05 (GM 14.84% / 15.59%) |
| AQI: 0.97 (AQ_t 0.35 / AQ_t-1 0.36) |
| SGI: 1.11 (Revenue 13.14b / 11.80b) |
| TATA: -0.02 (NI 911.0m - CFO 1.26b) / TA 19.52b) |
| Beneish M-Score: -2.87 (Cap -4..+1) = A |
What is the price of BALL shares?
As of February 07, 2026, the stock is trading at USD 66.47 with a total of 3,374,976 shares traded.
Over the past week, the price has changed by +16.88%, over one month by +22.41%, over three months by +37.95% and over the past year by +31.67%.
Over the past week, the price has changed by +16.88%, over one month by +22.41%, over three months by +37.95% and over the past year by +31.67%.
Is BALL a buy, sell or hold?
Ball has received a consensus analysts rating of 3.76.
Therefor, it is recommend to hold BALL.
- StrongBuy: 6
- Buy: 3
- Hold: 7
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the BALL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 70.2 | 5.5% |
| Analysts Target Price | 70.2 | 5.5% |
| ValueRay Target Price | 71.9 | 8.2% |
BALL Fundamental Data Overview February 07, 2026
P/E Trailing = 19.641
P/E Forward = 16.3666
P/S = 1.3687
P/B = 3.2039
P/EG = 1.3788
Revenue TTM = 13.14b USD
EBIT TTM = 1.45b USD
EBITDA TTM = 2.08b USD
Long Term Debt = 6.86b USD (from longTermDebt, two quarters ago)
Short Term Debt = 21.0m USD (from shortTermDebt, last quarter)
Debt = 7.01b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.80b USD (from netDebt column, last quarter)
Enterprise Value = 23.81b USD (18.01b + Debt 7.01b - CCE 1.21b)
Interest Coverage Ratio = 4.63 (Ebit TTM 1.45b / Interest Expense TTM 314.0m)
EV/FCF = 30.22x (Enterprise Value 23.81b / FCF TTM 788.0m)
FCF Yield = 3.31% (FCF TTM 788.0m / Enterprise Value 23.81b)
FCF Margin = 6.00% (FCF TTM 788.0m / Revenue TTM 13.14b)
Net Margin = 6.93% (Net Income TTM 911.0m / Revenue TTM 13.14b)
Gross Margin = 14.84% ((Revenue TTM 13.14b - Cost of Revenue TTM 11.19b) / Revenue TTM)
Gross Margin QoQ = 14.61% (prev 15.51%)
Tobins Q-Ratio = 1.22 (Enterprise Value 23.81b / Total Assets 19.52b)
Interest Expense / Debt = 1.10% (Interest Expense 77.0m / Debt 7.01b)
Taxrate = 20.24% (50.0m / 247.0m)
NOPAT = 1.16b (EBIT 1.45b * (1 - 20.24%))
Current Ratio = 1.11 (Total Current Assets 6.11b / Total Current Liabilities 5.49b)
Debt / Equity = 1.29 (Debt 7.01b / totalStockholderEquity, last quarter 5.42b)
Debt / EBITDA = 2.80 (Net Debt 5.80b / EBITDA 2.08b)
Debt / FCF = 7.36 (Net Debt 5.80b / FCF TTM 788.0m)
Total Stockholder Equity = 5.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.90% (Net Income 911.0m / Total Assets 19.52b)
RoE = 16.89% (Net Income TTM 911.0m / Total Stockholder Equity 5.39b)
RoCE = 11.85% (EBIT 1.45b / Capital Employed (Equity 5.39b + L.T.Debt 6.86b))
RoIC = 9.37% (NOPAT 1.16b / Invested Capital 12.37b)
WACC = 5.64% (E(18.01b)/V(25.03b) * Re(7.50%) + D(7.01b)/V(25.03b) * Rd(1.10%) * (1-Tc(0.20)))
Discount Rate = 7.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -8.04%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈788.0m ; Y1≈517.3m ; Y5≈236.0m
Fair Price DCF = 6.42 (EV 7.52b - Net Debt 5.80b = Equity 1.72b / Shares 268.0m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 48.85 | EPS CAGR: 4.56% | SUE: -0.06 | # QB: 0
Revenue Correlation: -46.30 | Revenue CAGR: -2.97% | SUE: 1.21 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.85 | Chg30d=-0.001 | Revisions Net=-1 | Analysts=14
EPS current Year (2026-12-31): EPS=3.97 | Chg30d=-0.020 | Revisions Net=-1 | Growth EPS=+11.2% | Growth Revenue=+5.6%
EPS next Year (2027-12-31): EPS=4.52 | Chg30d=+0.059 | Revisions Net=-1 | Growth EPS=+13.8% | Growth Revenue=+3.3%
P/E Forward = 16.3666
P/S = 1.3687
P/B = 3.2039
P/EG = 1.3788
Revenue TTM = 13.14b USD
EBIT TTM = 1.45b USD
EBITDA TTM = 2.08b USD
Long Term Debt = 6.86b USD (from longTermDebt, two quarters ago)
Short Term Debt = 21.0m USD (from shortTermDebt, last quarter)
Debt = 7.01b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.80b USD (from netDebt column, last quarter)
Enterprise Value = 23.81b USD (18.01b + Debt 7.01b - CCE 1.21b)
Interest Coverage Ratio = 4.63 (Ebit TTM 1.45b / Interest Expense TTM 314.0m)
EV/FCF = 30.22x (Enterprise Value 23.81b / FCF TTM 788.0m)
FCF Yield = 3.31% (FCF TTM 788.0m / Enterprise Value 23.81b)
FCF Margin = 6.00% (FCF TTM 788.0m / Revenue TTM 13.14b)
Net Margin = 6.93% (Net Income TTM 911.0m / Revenue TTM 13.14b)
Gross Margin = 14.84% ((Revenue TTM 13.14b - Cost of Revenue TTM 11.19b) / Revenue TTM)
Gross Margin QoQ = 14.61% (prev 15.51%)
Tobins Q-Ratio = 1.22 (Enterprise Value 23.81b / Total Assets 19.52b)
Interest Expense / Debt = 1.10% (Interest Expense 77.0m / Debt 7.01b)
Taxrate = 20.24% (50.0m / 247.0m)
NOPAT = 1.16b (EBIT 1.45b * (1 - 20.24%))
Current Ratio = 1.11 (Total Current Assets 6.11b / Total Current Liabilities 5.49b)
Debt / Equity = 1.29 (Debt 7.01b / totalStockholderEquity, last quarter 5.42b)
Debt / EBITDA = 2.80 (Net Debt 5.80b / EBITDA 2.08b)
Debt / FCF = 7.36 (Net Debt 5.80b / FCF TTM 788.0m)
Total Stockholder Equity = 5.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.90% (Net Income 911.0m / Total Assets 19.52b)
RoE = 16.89% (Net Income TTM 911.0m / Total Stockholder Equity 5.39b)
RoCE = 11.85% (EBIT 1.45b / Capital Employed (Equity 5.39b + L.T.Debt 6.86b))
RoIC = 9.37% (NOPAT 1.16b / Invested Capital 12.37b)
WACC = 5.64% (E(18.01b)/V(25.03b) * Re(7.50%) + D(7.01b)/V(25.03b) * Rd(1.10%) * (1-Tc(0.20)))
Discount Rate = 7.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -8.04%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈788.0m ; Y1≈517.3m ; Y5≈236.0m
Fair Price DCF = 6.42 (EV 7.52b - Net Debt 5.80b = Equity 1.72b / Shares 268.0m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 48.85 | EPS CAGR: 4.56% | SUE: -0.06 | # QB: 0
Revenue Correlation: -46.30 | Revenue CAGR: -2.97% | SUE: 1.21 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.85 | Chg30d=-0.001 | Revisions Net=-1 | Analysts=14
EPS current Year (2026-12-31): EPS=3.97 | Chg30d=-0.020 | Revisions Net=-1 | Growth EPS=+11.2% | Growth Revenue=+5.6%
EPS next Year (2027-12-31): EPS=4.52 | Chg30d=+0.059 | Revisions Net=-1 | Growth EPS=+13.8% | Growth Revenue=+3.3%